Sionna seeks $135M IPO to fuel tests of cystic fibrosis drug candidates

Cystic fibrosis drug developer Sionna Therapeutics hopes to join the IPO wave started by Metsera and Maze Therapeutics last week.

Sionna, which snagged some of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

TB cases in England spike by 10.7% in 2023

Figures published today by the UK Health Security Agency (UKHSA) in its TB annual report, show that tuberculosis cases in England in 2022 were stable

February 15, 2024

Opinion | There’s No Place for Politics at the Bedside

Zitter is a critical care and palliative care physician, and director of the forthcoming documentary, “The Chaplain and the Doctor.” Medicine is largely science, but

January 17, 2025

Understanding the link between EBV-infected B cells and multiple sclerosis

The Wistar Institute’s Paul M. Lieberman, Ph.D., and lab team led by senior staff scientist and first author, Samantha Soldan, Ph.D., have demonstrated how B

May 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.